Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Designation crawled date : 2021 - 11 - 15 save search
Herman Miller Unveils New Seating Collection with Designer Michael Anastassiades
Published: 2021-11-15 (Crawled : 20:00) - prnewswire.com
MLKN | $25.11 1.33% 1.31% 410K
|
Manufacturing
|
| O: -0.15%
H: 0.42%
C: 0.05%
designation
JW Marriott Orlando Bonnet Creek Resort & Spa Unveils New Family Suites With Lofted Beds and Kid-Friendly Elements Designed to Create Family Moments
Published: 2021-11-15 (Crawled : 15:00) - prnewswire.com
MAR | $236.04 -0.11% -0.11% 1.8M
|
Consumer Services
|
| O: -0.34%
H: 0.48%
C: -0.87%
iot designation
Sunchips® & Celebrity Design Expert Bobby Berk Launch Virtual "Sunchips Art Seen" Contest
Published: 2021-11-15 (Crawled : 13:30) - prnewswire.com
PEP | News | $174.1 1.06% 1.05% 6.6M
|
Consumer Non-Durables
|
| O: -0.31%
H: 0.84%
C: 0.79%
chip test designation erk
Junshi Biosciences and Coherus Announce Toripalimab Granted Orphan Drug Designation in the United States for Esophageal Cancer
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.34%
H: 0.73%
C: -0.09%
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
|
| O: 1.46%
H: 1.81%
C: 0.75%
orphan drug cancer drug granted designation
Atlas Technical Consultants Awarded $15 Million Design Quality Assurance Services contract for the I-35 Northeast Expansion (NEX) Design Build Program in Texas
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
ATCX | $12.25 0.66% 0.0% 0
|
Finance
|
| O: 5.81%
H: 1.35%
C: -4.22%
expansion contract designation
Coherus and Junshi Biosciences Announce Toripalimab Granted Orphan Drug Designation in the United States for Esophageal Cancer
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.34%
H: 0.73%
C: -0.09%
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
|
| O: 1.46%
H: 1.81%
C: 0.75%
orphan drug cancer drug granted designation
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.